The study focused on three critical outcomes: People who had bariatric surgery lost an average of 28% of their total body weight, while people taking GLP-1 drugs lost an average of 10%
up to 12 weeks for chronic or post-surgical cases These protocols must be supervised by a licensed provider who can adjust dosing based on clinical response, labs, and patient history
We have complete a Phase 1B study with promising safety and efficacy results and are preparing for a Phase 2B trial
Brello has made it possible to help me help myself. -Jennifer K.- Best experience with an online pharmacy I highly recommend this company to anyone looking to get started on their GLP-1 journey
For decades, patients were told that inability to lose the "spare tire" was simply a lack of discipline
Endocrinologia, Diabetes y Nutricion, 64 (5), 278-280